Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Ciprofloxacin-resistant Neisseria meningitidis present in United States
American Pharmacists Association, 03/25/09
Three cases of meningococcal disease caused by ciprofloxacin-resistant Neisseria meningitidis have been identified in the United States—one in North Dakota and two in western Minnesota.
Related Articles
Absence of Neisseria meningitidis Serogroup C-Specific Antibodies during the First Year of Life in The Netherlands: an Age Group at Risk
Clinical and Vaccine Immunology, 10/06/09
Relevance Score: 85%
Prevalence and antimicrobial resistance pattern of bacterial meningitis in Egypt
Annals of Clinical Microbiology and Antimicrobials, 10/13/09
Relevance Score: 80%
Invasive meningococcal disease in Malta: an epidemiological overview, 1994–2007
Journal of Medical Microbiology, 10/21/09
Relevance Score: 77%
Today in Drug Resistance...keeping you current
Receive free subspecialty "5-minute updates" via email
Reduction of blood pressure in patients with treatment-resistant hypertension
Expert Opinion in Pharmacotherapy, 12/09/09
Linezolid in the Treatment of Multidrug-Resistant Tuberculosis
Clinical Infectious Diseases, 12/08/09
Efficacy and Safety of Efalizumab in Patients with Moderate-to-Severe Plaque Psoriasis Resistant to Previous Anti-Psoriatic Treatment: Results of a Multicentre, Open-label, Phase IIIb/IV Trial
Archives of Drug Information, 12/08/09
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effective Treatment With Low-Dose Fluvoxamine for Obsessive-Compulsive Disorder After Neurosurgery: A Case Report
Clinical Neuropharmacology, 12/16/09
Fluoxetine Blocks Myotonic Runs and Reverts Abnormal Surface Electromyogram Pattern in Patients With Myotonic Dystrophy Type 1
Clinical Neuropharmacology, 12/16/09
Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Formulary , 12/16/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


